The Korean Society for Neuro-Oncology (KSNO) Guideline for Adult Diffuse Midline Glioma: Version 2021.1

BACKGROUND: There have been no guidelines for the management of adult patients with diffuse midline glioma (DMG), H3K27M-mutant in Korea since the 2016 revised WHO classification newly defined this disease entity. Thus, the Korean Society for Neuro-Oncology (KSNO), a multidisciplinary academic socie...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Brain Tumor Res Treat
Autors principals: Yoon, Hong In, Wee, Chan Woo, Kim, Young Zoon, Seo, Youngbeom, Im, Jung Ho, Dho, Yun-Sik, Kim, Kyung Hwan, Hong, Je Beom, Park, Jae-Sung, Choi, Seo Hee, Kim, Min-Sung, Moon, Jangsup, Hwang, Kihwan, Park, Ji Eun, Cho, Jin Mo, Yoon, Wan-Soo, Kim, Se Hoon, Kim, Young Il, Kim, Ho Sung, Sung, Kyoung Su, Song, Jin Ho, Lee, Min Ho, Han, Myung-Hoon, Lee, Se-Hoon, Chang, Jong Hee, Lim, Do Hoon, Park, Chul-Kee, Lee, Youn Soo, Gwak, Ho-Shin
Format: Artigo
Idioma:Inglês
Publicat: The Korean Brain Tumor Society; The Korean Society for Neuro-Oncology; The Korean Society for Pediatric Neuro-Oncology 2021
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8082289/
https://ncbi.nlm.nih.gov/pubmed/33913265
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14791/btrt.2021.9.e8
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars